TheraRadar
← Back
Data updated: Jul 17, 2026

PURE SOURCE

Generics
Pharmaceuticals

PURE SOURCE is a generic drug manufacturer with 1 FDA-approved products.

2004
Since
1
Drugs
-
Trials
0
New Drugs (2yr)
Modality:

PURE SOURCE's Key Drugs

PURE SOURCE's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

PURE SOURCE's Recent FDA Approvals

New NDA/BLA approvals for PURE SOURCE over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

PURE SOURCE's Therapeutic Areas

Disease areas where PURE SOURCE has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.

No indication data

PURE SOURCE Pipeline Snapshot

Active clinical trials for PURE SOURCE across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • • Top drug revenue breakdown
  • • Drug-level revenue analysis

Trial Catalysts

  • • Active trial monitoring
  • • Phase 3 readout tracking

Patent Risk

  • • Patent expiration timeline
  • • Revenue at risk analysis

Compare Companies

  • • Side-by-side pipeline analysis
  • • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling